Contact
searchSearch
HMP Global
Login
Nirav Shah, MD
Videos
Innovation and the Future Development of Cell Therapies for Patients With B-Cell Lymphomas
08/05/2024
At the 2024 Pan Pacific Lymphoma Conference, Nirav Shah, MD, discusses innovation and the future development of cell therapies for patients with various types of B-cell malignancies.
At the 2024 Pan Pacific Lymphoma Conference, Nirav Shah, MD, discusses innovation and the future development of cell therapies for patients with various types of B-cell malignancies.
At the 2024 Pan Pacific Lymphoma...
08/05/2024
Oncology
Jason Westin, MD
Conference Coverage
CAR T-Cell Therapy as New Standard of Care for Patients With Early Relapsed Large B-Cell Lymphoma
07/23/2024
Jason Westin, MD, shares expert insight regarding CAR T-cell therapy as standard of care treatment for patients with early relapsed large B-cell lymphoma at the 2024 Pan Pacific Lymphoma Conference.
Jason Westin, MD, shares expert insight regarding CAR T-cell therapy as standard of care treatment for patients with early relapsed large B-cell lymphoma at the 2024 Pan Pacific Lymphoma Conference.
Jason Westin, MD, shares expert...
07/23/2024
Oncology
Elaine Jaffe, MD
Conference Coverage
Analyzing Evolution and Difference in the Latest Classifications of Lymphoma
07/16/2024
At the 2024 Pan Pacific Lymphoma Conference, Elaine Jaffe, MD, analyzes the differing classification systems of lymphoma, focusing on diffuse large B-cell lymphoma, follicular lymphoma, and small B-cell neoplasms.
At the 2024 Pan Pacific Lymphoma Conference, Elaine Jaffe, MD, analyzes the differing classification systems of lymphoma, focusing on diffuse large B-cell lymphoma, follicular lymphoma, and small B-cell neoplasms.
At the 2024 Pan Pacific Lymphoma...
07/16/2024
Oncology
Mark Roschewski, MD
Conference Coverage
Potential Role of Dose-Adjusted EPOCH-R in the Frontline Setting Among Patients With Aggressive B-Cell Lymphomas
07/15/2024
Mark Roschewski, MD, shared expert insight on the possible role of dose-adjusted EPOCH-R as first-line treatment for patients with aggressive B-cell lymphomas.
Mark Roschewski, MD, shared expert insight on the possible role of dose-adjusted EPOCH-R as first-line treatment for patients with aggressive B-cell lymphomas.
Mark Roschewski, MD, shared...
07/15/2024
Oncology

About the Pan Pacific Lymphoma Conference

The Pan Pacific Lymphoma Conference is one of the largest gatherings of clinicians and researchers specializing in the areas of lymphoma and transplantation.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use